Literature DB >> 9928376

Clinical models of intestinal adaptation.

J D Schulzke1, H Schmitz, M Fromm, C J Bentzel, E O Riecken.   

Abstract

Mucosal adaptation of the small intestine is morphologically restricted to only three different patterns, namely, atrophy, hyperplasia, and hyperregeneration. The hyperplastic mucosa in the experimental short bowel syndrome exhibits unchanged epithelial barrier properties and a differential functional adaptation with a 150% increase in Na-glucose cotransport but no change in electroneutral NaCl cotransport. In the hyperregeneratively transformed mucosa of the self-filling blind loop of rat jejunum, absorption is seriously impaired, as indicated by the 80% decrease in Na-glucose cotransport. To compensate for this, epithelial barrier function is upregulated by an increase in tight junction complexity to prevent leak flux of ions and substrates. In contrast, the hyperregeneratively transformed mucosa in celiac sprue shows reduced tight junction complexity. Possible candidates responsible for the heterogeneity of tight junction adaptation in these conditions could be cytokines, because tumor necrosis factor-alpha can specifically downregulate the tight junction, as indicated in the intestinal HT-29/B6 cell model.

Entities:  

Mesh:

Year:  1998        PMID: 9928376     DOI: 10.1111/j.1749-6632.1998.tb11117.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions.

Authors:  Muhammad G Kibriya; Farzana Jasmine; Maria Argos; Wendy J Verret; Muhammad Rakibuz-Zaman; Alauddin Ahmed; Faruque Parvez; Habibul Ahsan
Journal:  Toxicol Lett       Date:  2007-01-19       Impact factor: 4.372

2.  Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients.

Authors:  Guo-Hao Wu; Zhao-Han Wu; Zhao-Guang Wu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.